Literature DB >> 11745231

Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung.

S A Ahrendt1, P A Decker, E A Alawi, Y R Zhu Yr, M Sanchez-Cespedes, S C Yang, G B Haasler, A Kajdacsy-Balla, M J Demeure, D Sidransky.   

Abstract

BACKGROUND: The majority of lung carcinoma cases occur in current or former smokers. K-ras gene mutations are common in lung adenocarcinoma and have been associated with cigarette smoking, asbestos exposure, and female gender.
METHODS: In the current study, the authors examined the contribution of cigarette smoking to K-ras gene mutations in patients with primary lung adenocarcinoma. Smoking histories were obtained from 106 prospectively enrolled patients with primary adenocarcinoma of the lung.
RESULTS: K-ras mutations were detected in the primary tumor using an allele-specific ligation assay. Ninety-two of the 106 patients (87%) with lung adenocarcinoma were smokers. Nonsmokers with this tumor were more likely to be women (11 of 14; 79%), whereas the majority of smokers (57%) were men. K-ras mutations were detected in 40 of 106 tumors (38%) and were significantly more common in smokers compared with nonsmokers (43% vs. 0%; P = 0.001).
CONCLUSIONS: The results of the current study confirm and extend previous observations that smokers with adenocarcinoma of the lung are more likely to have K-ras mutant tumors compared with nonsmokers. The strong link between cigarette smoking and K-ras mutations in adenocarcinoma of the lung supports the role of specific tobacco carcinogens in the etiology of this malignancy. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11745231     DOI: 10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  126 in total

1.  GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.

Authors:  Lauren L Ritterhouse; Marina Vivero; Mari Mino-Kenudson; Lynette M Sholl; A John Iafrate; Valentina Nardi; Fei Dong
Journal:  Mod Pathol       Date:  2017-08-04       Impact factor: 7.842

Review 2.  Importance of molecular features of non-small cell lung cancer for choice of treatment.

Authors:  Cesar Moran
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Detection of 7-(2'-carboxyethyl)guanine but not 7-carboxymethylguanine in human liver DNA.

Authors:  Guang Cheng; Mingyao Wang; Peter W Villalta; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

Review 4.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

Review 5.  Lung cancer in never-smokers.

Authors:  Chee-Keong Toh; Wan-Teck Lim
Journal:  J Clin Pathol       Date:  2006-08-17       Impact factor: 3.411

6.  Primary lung adenocarcinomas in children and adolescents treated for pediatric malignancies.

Authors:  Mark L Kayton; Mai He; Maureen F Zakowski; Andre L Moreira; Christopher Lau; Alexander J Chou; Melinda Merchant; Pamela R Merola; Leonard H Wexler; Michael P La Quaglia; William D Travis; Marc Ladanyi
Journal:  J Thorac Oncol       Date:  2010-11       Impact factor: 15.609

7.  Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

Authors:  Young Hwa Soung; Jong Woo Lee; Su Young Kim; Si Hyung Seo; Won Sang Park; Suk Woo Nam; Sang Yong Song; Joung Ho Han; Cheol Keun Park; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Virchows Arch       Date:  2005-04-07       Impact factor: 4.064

8.  EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer.

Authors:  David E Gerber
Journal:  Drug Dev Res       Date:  2008-12-09       Impact factor: 4.360

9.  Statistical methods for studying disease subtype heterogeneity.

Authors:  Molin Wang; Donna Spiegelman; Aya Kuchiba; Paul Lochhead; Sehee Kim; Andrew T Chan; Elizabeth M Poole; Rulla Tamimi; Shelley S Tworoger; Edward Giovannucci; Bernard Rosner; Shuji Ogino
Journal:  Stat Med       Date:  2015-12-01       Impact factor: 2.373

Review 10.  Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers.

Authors:  Takayuki Fukui; Tetsuya Mitsudomi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.